GTCM
PTCT icon

Gyon Technologies Capital Management’s PTC Therapeutics PTCT Stock Holding History

Gyon Technologies Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,906
Closed -$594K – 505
2021
Q4 		$594K Buy
+14,906
New +$571K 0.11% 261
2021
Q3 		– Sell
-43,971
Closed -$1.86M – 466
2021
Q2 		$1.86M Buy
43,971
+37,842
+617% +$1.62M 0.61% 51
2021
Q1 		$290K Sell
6,129
-5,928
-49% -$352K 0.13% 285
2020
Q4 		$736K Buy
12,057
+693
+6% +$40.8K 0.25% 123
2020
Q3 		$531K Sell
11,364
-528
-4% -$26K 0.42% 93
2020
Q2 		$603K Buy
+11,892
New +$584K 1.46% 24
2020
Q1 		– Sell
-13,925
Closed -$669K – 170
2019
Q4 		$669K Buy
+13,925
New +$592K 0.44% 71

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Gyon Technologies Capital Management's PTCT Position: Q1 2022 in Review

Gyon Technologies Capital Management sold out of PTC Therapeutics (PTCT) in Q1 2022, closing a stake of 14,906 shares — an estimated $594K sold.

Gyon Technologies Capital Management first reported a position in PTCT in Q4 2019 and held it in 7 quarters. The position peaked at $1.86M in Q2 2021. 183 funds tracked by Wall St. Rank hold PTCT as of Q1 2022.

  • Gyon Technologies Capital Management reported no remaining PTC Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 14,906 PTC Therapeutics shares in Q1 2022, an estimated $594K.
  • Gyon Technologies Capital Management first reported a position in PTC Therapeutics in Q4 2019 and held it in 7 quarters.
  • Gyon Technologies Capital Management's PTC Therapeutics position peaked at $1.86M in Q2 2021.
  • 183 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2022, filed 12 May 2022.